ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

"We're Overdosed" - A Profound Exploration of the Opioid Epidemic, History, and Future Solutions

By: Issuewire
Barry Gold

Wilmington, Delaware Mar 8, 2024 (Issuewire.com) - "We're Overdosed," a groundbreaking book by scientist Barry I. Gold, is making waves as it explores the history of opium, the evolution of opioids, and the global pharmaceutical industry. This masterpiece delves into the origins of opium, tracing the development of morphine and the subsequent synthesis of opioids that shaped the pharmaceutical landscape globally. Barry I. Gold, drawing from his scientific background, provides unique insights into the challenges of controlling prescription opioids through Federal legislation, offering a perspective crucial to addressing the opioid crisis.

In the wake of a tragic epidemic marked by overdose deaths, predominantly from illicit sources, the book poses a critical question: How can the U.S. take a leading role in eradicating the world trade of illicit drugs? Barry I. Gold's exploration extends beyond the historical context to consider the future, examining how new treatments offer hope in addressing addiction.

"This book is a comprehensive journey through the history of opium and the impact of opioids on our world. It's not just an exploration of the past; it's a call to action for the present and a hopeful look into the future of addiction treatment," says Barry I. Gold, the author of "We're Overdosed."

The book stands as a beacon for those seeking a deeper understanding of the opioid epidemic, shedding light on the complex interplay between history, pharmaceutical development, and the urgent need for solutions. With featured appearances on prominent platforms like America Tonight Radio, Spotlight TV, and Books of the Month, "We're Overdosed" is gaining recognition as a must-read for those invested in addressing the critical issues surrounding opioids.

Podcast:

https://soundcloud.com/kated-294710598/barrygold/s-5YmOqdYFmzX?si=d2ecaafdf77043ab99faa0743ef6f4b9&utm_source=clipboard&utm_medium=text&utm_campaign=social_sharing

Youtube:

https://youtu.be/8gfFjhq4mB0

https://youtu.be/hhk4BMQQCtg

https://youtu.be/NU0YUn3hvZM

"We're Overdosed" is now available on Amazon and other leading online retailers. Don't miss the opportunity to engage with this enlightening exploration of the opioid crisis, its roots, and the potential paths forward.

ISBN-10 : 1956452206

ISBN-13 : 978-1956452204

Book Title: We're Overdosed

Author: Barry I. Gold

Publisher: Central Park South Publishing

Represented by: Great Writers Media

Publication Date: November 1, 2022

About the Author:

Barry I. Gold, a retired pharmacologist, commenced his career as a medical school educator, reaching the pinnacle of his profession when he led drug development teams for a German pharmaceutical company, necessitating his frequent presence in Europe.

His diverse writing has been featured in publications such as Woman's Day, History Magazine, Parent.com, Ducts.org, and the book Short Story Contest Winners by Warren Adler.

A University of Cincinnati graduate with a B.S. in zoology, Barry I. Gold went on to earn his Ph.D. in pharmacology from Boston University, followed by a Postdoctoral Fellowship at Yale University's medical school.

With two adult children from his first marriage and as a single parent to a thirteen-year-old from his second marriage, Barry resides in northern New Jersey. His passions extend beyond pharmacology to include the art of baking bread and woodworking.

Website: www.barrygoldwriter.com

Media Contact

Great Writers Media


lgoldford@greatwritersmedia.com

1-877-556-0487 ext.

24A Trolley Square #1580

https://www.greatwritersmedia.com/

Source :Great Writers Media

This article was originally published by IssueWire. Read the original article here.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.